Rossmore Private Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.82M | Buy |
27,289
+2,300
| +9% | +$205K | 0.23% | 78 |
|
|
2026
Q1 | $1.79M | Buy |
24,989
+1,515
| +6% | +$117K | 0.16% | 98 |
|
|
2025
Q4 | $1.86M | Buy |
23,474
+3,980
| +20% | +$314K | 0.17% | 99 |
|
|
2025
Q3 | $1.47M | Buy |
19,494
+50
| +0.3% | +$3.43K | 0.16% | 101 |
|
|
2025
Q2 | $1.34M | Buy |
19,444
+18
| +0.1% | +$1.18K | 0.16% | 108 |
|
|
2025
Q1 | $1.32M | Sell |
19,426
-3,127
| -14% | -$187K | 0.16% | 104 |
|
|
2024
Q4 | $1.01M | Sell |
22,553
-3,400
| -13% | -$191K | 0.13% | 125 |
|
|
2024
Q3 | $1.63M | Sell |
25,953
-1,327
| -5% | -$77.4K | 0.2% | 92 |
|
|
2024
Q2 | $1.61M | Sell |
27,280
-6,612
| -20% | -$414K | 0.21% | 90 |
|
|
2024
Q1 | $2.7M | Sell |
33,892
-329
| -1% | -$25.1K | 0.35% | 64 |
|
|
2023
Q4 | $2.7M | Buy |
34,221
+809
| +2% | +$57.6K | 0.38% | 61 |
|
|
2023
Q3 | $2.34M | Buy |
33,412
+2,793
| +9% | +$198K | 0.35% | 60 |
|
|
2023
Q2 | $2.12M | Buy |
30,619
+6,100
| +25% | +$434K | 0.31% | 68 |
|
|
2023
Q1 | $1.82M | Buy |
24,519
+312
| +1% | +$26.2K | 0.28% | 72 |
|
|
2022
Q4 | $2.26M | Buy |
24,207
+500
| +2% | +$48.2K | 0.36% | 66 |
|
|
2022
Q3 | $2.26M | Buy |
23,707
+1,183
| +5% | +$117K | 0.4% | 61 |
|
|
2022
Q2 | $2.09M | Buy |
22,524
+867
| +4% | +$84.6K | 0.36% | 68 |
|
|
2022
Q1 | $2.19M | Sell |
21,657
-8
| -0% | -$840 | 0.34% | 74 |
|
|
2021
Q4 | $2.23M | Buy |
21,665
+366
| +2% | +$33.8K | 0.35% | 71 |
|
|
2021
Q3 | $1.81M | Sell |
21,299
-552
| -3% | -$46.2K | 0.31% | 76 |
|
|
2021
Q2 | $1.82M | Sell |
21,851
-2,110
| -9% | -$173K | 0.31% | 75 |
|
|
2021
Q1 | $1.8M | Buy |
23,961
+702
| +3% | +$51.1K | 0.34% | 72 |
|
|
2020
Q4 | $1.59M | Buy |
23,259
+1,410
| +6% | +$91.7K | 0.32% | 79 |
|
|
2020
Q3 | $1.28M | Buy |
21,849
+7,225
| +49% | +$450K | 0.3% | 82 |
|
|
2020
Q2 | $950K | Buy |
14,624
+1,651
| +13% | +$104K | 0.26% | 84 |
|
|
2020
Q1 | $770K | Buy |
12,973
+1,681
| +15% | +$112K | 0.27% | 82 |
|
|
2019
Q4 | $839K | Sell |
11,292
-349
| -3% | -$24.5K | 0.26% | 68 |
|
|
2019
Q3 | $734K | Sell |
11,641
-784
| -6% | -$46.5K | 0.25% | 70 |
|
|
2019
Q2 | $677K | Buy |
12,425
+293
| +2% | +$15.8K | 0.24% | 74 |
|
|
2019
Q1 | $654K | Buy |
12,132
+63
| +0.5% | +$3.89K | 0.24% | 72 |
|
|
2018
Q4 | $791K | Sell |
12,069
-4,437
| -27% | -$331K | 0.34% | 57 |
|
|
2018
Q3 | $1.3M | Buy |
16,506
+4,695
| +40% | +$336K | 0.52% | 40 |
|
|
2018
Q2 | $760K | Buy |
11,811
+6,334
| +116% | +$417K | 0.49% | 46 |
|
|
2018
Q1 | $341K | Buy |
5,477
+215
| +4% | +$15.4K | 0.35% | 64 |
|
|
2017
Q4 | $381K | Buy |
+5,262
| New | +$383K | 0.38% | 52 |
|
Other funds holding CVS
Rossmore Private Capital's CVS Position: Q2 2026 in Review
Rossmore Private Capital increased its CVS Health (CVS) stake by 9.2% in Q2 2026, buying an estimated $205K and bringing the position to 27,289 shares worth $2.82M. The position accounts for 0.23% of the portfolio, ranked #78.
Rossmore Private Capital first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Rossmore Private Capital held 27,289 shares of CVS Health worth $2.82M as of Q2 2026.
- Rossmore Private Capital bought 2,300 CVS Health shares in Q2 2026, an estimated $205K.
- CVS Health made up 0.23% of Rossmore Private Capital's portfolio in Q2 2026, its #78 holding.
- Rossmore Private Capital first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.